Latest Bausch Health News & Updates

See the latest news and media coverage for Bausch Health. We track all announcements, press releases, and industry mentions in real time, all in one place.

Bausch Health

Multinational pharmaceutical and healthcare products company

bauschhealth.com

Headquarters: Laval, Canada
Founded year: 1959
Company type: Public company
Number of employees: 5,000–10,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Bausch Health

In short: Bausch Health reported strong financial performance in early 2026, raising its guidance following double-digit revenue and EBITDA growth.

Company announcements

July 29 Bausch Health

Bausch Health reports Q2 2026 earnings and raises guidance

Revenues hit $2.85B, up 13%. Adjusted EBITDA grew 28% to $1.075B.

July 6 Bausch Health

Bausch Health lists PrOKEDI in Quebec for schizophrenia

Québec is the first province to include it on the RAMQ formulary, effective June 25, 2026.

July 1 Bausch Health

Michael Goettler resigns from Bausch Health's Board of Directors

He resigned effective June 30 to become CEO of Knoa Pharma LLC.

June 9 Bausch Health

Bausch Health signs LOI for PrOKEDI public coverage

The LOI covers PrOKEDI® 75mg and 100mg for adult schizophrenia, advancing public drug plan listing negotiations to secure nationwide patient access.

Media coverage

July 29 The Globe and Mail

BAUSCH HEALTH ANNOUNCES SECOND QUARTER 2026 RESULTS, RAISES GUIDANCE

BAUSCH HEALTH EXCLUDING BAUSCH + LOMB SECOND QUARTER 2026 RESULTS. LAVAL, QC, July 29, 2026 /CNW/ -- Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or...

July 29 AOL

Bausch + Lomb Delivers Broad-Based Second-Quarter Growth, Raises Full-Year 2026 Guidance

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter...

July 28 Yahoo Finance

Bausch Health (BHC) Rockets 28% as Q2 Turnaround Fuels Recovery Outlook

Bausch Health (NYSE:BHC) climbed by 28.85 percent on Thursday to end at $6.03 apiece, after announcing a strong second quarter of the year that set...

July 28 Stockhouse

Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case

LAVAL, QB / ACCESSWIRE / December 2, 2022 / Bausch Health Companies Inc. (NYSE/TSX:BHC) today announced that the US District Court for the District of...

Never miss news about Bausch Health

Track Bausch Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Bausch Health competitors & trending companies

Browse news for competitors to Bausch Health and other trending companies.